Filing Details

Accession Number:
0001140361-13-038304
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-09 17:31:04
Reporting Period:
2013-10-04
Filing Date:
2013-10-09
Accepted Time:
2013-10-09 17:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI Pharmaceutical Preparations (2834) 522286452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1001391 E Charles Davidson C/o Wexford Capital Lp
411 West Putnam Ave.
Greenwich CT 06830
No No No Yes
1048462 Wexford Capital Lp 411 West Putnam Avenue
Suite 125
Greenwich CT 06830
No No No Yes
1048485 Joseph Jacobs C/o Wexford Capital Lp
411 West Putnam Avenue, Suite 125
Greenwich CT 06830
No No No Yes
1472112 Wexford Gp Llc C/o Wexford Capital Lp
Suite 125
Greenwich CT 06830
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-10-04 325 $0.48 2,827,844 No 4 S Indirect By: Wexford Spectrum Investors LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Wexford Spectrum Investors LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 418,876 Indirect By: Kappa Investors LLC
Footnotes
  1. The Common Stock and Warrants are held directly by Wexford Spectrum Investors LLC ("WSI").
  2. The Common Stock and Warrants are held directly by Kappa Investors LLC ("Kappa", and together with WSI, the "Funds").
  3. This form is jointly filed by Wexford Capital LP ("Wexford"), Charles E. Davidson ("Davidson"), Joseph M. Jacobs ("Jacobs") and Wexford GP LLC ("Wexford GP"). The securities shown as beneficially owned by Davidson, Jacobs, Wexford GP and Wexford, reflect securities owned of record by the Funds. Wexford serves as manager for the Funds and as such may be deemed to share beneficial ownership of the securities beneficially owned by the Funds, but disclaims such beneficial ownership to the extent such beneficial ownership exceeds its pecuniary interest. (*continued under Footnote (4) below).
  4. (*continued from Footnote (3) above) Wexford GP, as the general partner of Wexford, may be deemed to share beneficial ownership of the securities beneficially owned by the Funds, but disclaims such beneficial ownership to the extent such beneficial ownership exceeds its pecuniary interest. Messrs. Davidson and Jacobs, as the controlling persons of Wexford GP, may be deemed to share beneficial ownership of any securities beneficially owned by the Funds for which Wexford serves as manager, but disclaim such beneficial ownership to the extent such beneficial ownership exceeds their pecuniary interest.